The Genome Center at Washington University, St Louis, Missouri 63108, USA.
Nature. 2010 Apr 15;464(7291):999-1005. doi: 10.1038/nature08989.
Massively parallel DNA sequencing technologies provide an unprecedented ability to screen entire genomes for genetic changes associated with tumour progression. Here we describe the genomic analyses of four DNA samples from an African-American patient with basal-like breast cancer: peripheral blood, the primary tumour, a brain metastasis and a xenograft derived from the primary tumour. The metastasis contained two de novo mutations and a large deletion not present in the primary tumour, and was significantly enriched for 20 shared mutations. The xenograft retained all primary tumour mutations and displayed a mutation enrichment pattern that resembled the metastasis. Two overlapping large deletions, encompassing CTNNA1, were present in all three tumour samples. The differential mutation frequencies and structural variation patterns in metastasis and xenograft compared with the primary tumour indicate that secondary tumours may arise from a minority of cells within the primary tumour.
大规模平行 DNA 测序技术为筛查与肿瘤进展相关的遗传变化提供了前所未有的能力。在这里,我们描述了一位非裔美国基底样乳腺癌患者的四个 DNA 样本的基因组分析结果:外周血、原发肿瘤、脑转移和源自原发肿瘤的异种移植物。转移瘤中包含两个新出现的突变和一个原发肿瘤中不存在的大片段缺失,并且有 20 个共享突变显著富集。异种移植物保留了所有原发肿瘤的突变,并显示出与转移瘤相似的突变富集模式。两个重叠的大片段缺失,包括 CTNNA1,存在于所有三个肿瘤样本中。与原发肿瘤相比,转移瘤和异种移植物的差异突变频率和结构变异模式表明,次级肿瘤可能起源于原发肿瘤中的少数细胞。